Glycated hemoglobin detection panel - Taiwan Registration ecf9c98e131dfb463bd1e54555be892f
Access comprehensive regulatory information for Glycated hemoglobin detection panel in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ecf9c98e131dfb463bd1e54555be892f and manufactured by Trinity Biotech (Primus Corporation dba Trinity Biotech). The authorized representative in Taiwan is PROGRESSIVE GROUP INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
For details, it is Chinese approved copy of the imitation order
B Haematology, pathology and genetics; A Clinical chemistry and clinical toxicology
A.1660 Quality control materials (analytical and non-analytical); B.7470 Analysis of glycosylated hemoglobin
import
Dates and Status
Nov 28, 2013
Nov 28, 2023